[2] [3] Understanding the full safety profile of GLP-1 medications, including potential effects on vision, remains essential for both prescribers and patients as use of these agents continues to expand rapidly across diverse patient populations
Clinical guidelines are expanding to recommend GLP-1 therapies for this group, supported by evidence showing effective weight loss and metabolic benefits at this stage
The result is a price tag that places these medications far out of reach for the average person paying out-of-pocket
Many people remain on starter doses that are intended only for tolerability, not therapeutic effect
True progress comes from pairing medication with nutrition, exercise and behavioral support while keeping care affordable
The blood flow to bones is vital for skeletal health, and GLP-1RAs may improve it, while the precise processes are not entirely known